Letalidad del cáncer de vesícula biliar es independiente del lugar de atención o características socio-demográficas. Chile 2002-2005

Simple item page
dc.article.number3
dc.catalogadoraba
dc.contributor.authorGabrielli, M.
dc.contributor.authorHugo, S.
dc.contributor.authorDomínguez, A.
dc.contributor.authorBaez, S.
dc.contributor.authorVenturelli, A.
dc.contributor.authorPuga, M.
dc.contributor.authorDíaz, A.
dc.contributor.authorJarufe, N.
dc.contributor.authorFerreccio, C.
dc.date.accessioned2024-03-04T15:19:40Z
dc.date.available2024-03-04T15:19:40Z
dc.date.issued2010
dc.description.abstractBackground: Chile has the highest gallbladder cancer (GBC) death rate world-wide, affecting mainly Southern areas of the country. Aim: To compare the survival of GBC patients treated in hospitals located in areas with low and high risk for GBC. Material and Methods: Medical records of all patients with GBC admitted to one public hospital located in southern Chile, a public hospital and a private clinic, both located in Metropolitan Santiago, were reviewed. Cases were analyzed by age, sex, stage at diagnosis, ethnicity, socioeconomic status (SES) and rural residence. Survival was calculated using Kaplan Meier method. Results: A total of 598 cases (469 women), were analyzed. No differences in age or sex among hospitals were detected. At the moment of diagnosis, 75, 50 and 44% of cases from the hospital in southern Chile, the public hospital in Santiago and the private clinic in Santiago, were in stage IV, respectively. Five years survival was lower in the public hospital in southern Chile than in the public hospital in Santiago (10.7 and 14.4% respectively, p < 0.05) but not statistically different from the figure at the private clinic in Santiago (13.0%). However, when adjusting for stage at the moment of diagnosis, no difference in survival between the three hospitals, was found. The median days of survival were 1,559, 188, 70 and 69 for stages I, II, III and IV respectively. Conclusions: GBC mortality is high. The stage at the moment of diagnosis is only significant predictor of survival.
dc.fechaingreso.objetodigital2024-03-26
dc.format.extent8 páginas
dc.fuente.origenORCID
dc.identifier.doi10.4067/s0034-98872010001200003
dc.identifier.eissn0717-6163
dc.identifier.issn0034-9887
dc.identifier.urihttps://doi.org/10.4067/s0034-98872010001200003
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/82457
dc.information.autorucEscuela de Medicina; Dominguez De Landa, Maria Angelica; 0000-0001-7477-7574; 131798
dc.issue.numero11
dc.language.isoes
dc.nota.accesoContenido completo
dc.pagina.final1364
dc.pagina.inicio1357
dc.revistaRevista Médica de Chile
dc.rightsacceso abierto
dc.rights.licenseCC BY 4.0 DEED Attribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/deed.en
dc.subjectChile
dc.subjectGallbladder neoplasms
dc.subjectMortality
dc.subjectSurvival rat
dc.subject.ddc610
dc.subject.deweyMedicina y saludes_ES
dc.titleLetalidad del cáncer de vesícula biliar es independiente del lugar de atención o características socio-demográficas. Chile 2002-2005
dc.title.alternativeMortality due to gallbladder cancer. Retrospective analysis in three Chilean hospitals
dc.typeartículo
dc.volumen138
sipa.codpersvinculados131798
sipa.trazabilidadORCID;2024-01-15
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Letalidad del cancer de vesicula.pdf
Size:
2.57 MB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Artículos de revistas